1 month ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly BeatInvestor's Business Daily
ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections, shrugging off weight-loss drug worries.
The post ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly Beat appeared first on Investor'…